ESCRS Preview


OTEurope reveals highlights from each day of the ESCRS Congress with the help of three EAB members.

XXXI Congress of the ESCRS

5–9 October 2013, RAI, Amsterdam, The Netherlands

This year's major European event is nearing and the excitement of what will be revealed at the show is peaking once more. The XXXI event will be taking place in the canal ensued Amsterdam in The Netherlands and yet again expectant attendees and exhibitors will have much to look forward to in the packed out programme.

We hope you will find this a useful resource for your event and do also check out the ESCRS Showcase section, directly following this preview feature, for a brief overview of some exciting products that will be on the exhibition floor between 5–8 October.

Friday 4 October

ESCRS Glaucoma Day - 8.30 am–5.30 pm

Once again, the ESCRS will be immediately preceded by the ever popular ESCRS Glaucoma Day. Organized by the European Glaucoma Society (EGS), this year's programme will feature five sessions, covering four main topic areas - Glaucoma Burden, A Challenge To The IOP Concept, Medical Treatment and Surgery in Glaucoma. As with previous year's presentations will be made by key opinion leaders in the field of glaucoma and it is certain the day will not disappoint those attending.

This year, OTEurope's highlights include: Dr Augusto Azuara Blanco's discussion on 'The burden of glaucoma on patients and society: direct and indirect costs', Dr Luciano Quaranta's talk titled, 'How many IOP measurements do we need to make clinical decisions?', Dr Jean-Philippe Nordmann's presentation on 'Quality of generic drugs: equivalent to originals?', Dr Tarek Shaarawy's talk highlighting 'Minimally invasive glaucoma devices: what is the evidence?', and Dr John Thygesen's discussion on "The prevalence of angle closure in Europe'.

The meeting has been awarded 6 CME credits and potential attendees will need to register separately for this meeting. Registration will cost €150 plus VAT.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.